www.OSHA.gov | |
Directives
CPL 02-00-035 - CPL 2.35 CH-20 - Changes to the Regulatory and General Industry Standard Alleged Violation Elements (SAVEs) Manual |
![]() |
Record Type: | Instruction |
Directive Number: | CPL 02-00-035 |
Old Directive Number: | CPL 2.35 CH-20 |
Title: | Changes to the Regulatory and General Industry Standard Alleged Violation Elements (SAVEs) Manual |
Information Date: | 08/31/1992 |
Standard Number: | 1910.1030 |
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance Subject: Changes to the Regulatory and General Industry Standard Alleged Violation Elements (SAVEs) Manual A. Purpose. This instruction transmits revised and new pages to the Regulatory and General Industry SAVEs Manual for "Occupational Exposure to Bloodborne Pathogens." B. Scope. This instruction applies OSHA-wide. C. Action. Regional Administrators and Area Director shall ensure that all compliance personnel:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance D. Background. Final rule and regulations for 29 CFR 1910.1030, Occupational Exposure to Bloodborne Pathogens, were published in the Federal Register, Vol.56, No.235, on December 6, 1991. The effective date of this standard was March 6, 1992. Correction notice was published in the Federal Register, Vol.57, No.127 on July 1, 1992. E. State Plan States. Regional Administrators shall advise State designees of the action required by this instruction and encourage their participation in the SAVEs program. Patricia K. Clark, Director Directorate of Compliance Programs DISTRIBUTION: National, Regional, Area and District Offices Compliance Officers State Designees 11(c)/405 Programs NIOSH Regional Program Directors
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(c)(1)(i): The employer having employee(s) occupational exposure did not establish a written Exposure Control Plan designed to eliminate or minimize employee exposure:
2 29 CFR 1910.1030(c)(1)(ii)(A): The employer's Exposure Control Plan did not include the exposure determination required by 29 CFR 1910.1030(c)(2):
OPTION 1 3 29 CFR 1910.1030(c)(1)(ii)(B): The employer's Exposure Control Plan did not include the schedule and/or methods of implementation for 29 CFR 1910.1030(d) methods of compliance:
OPTION 2 4 29 CFR 1910.1030(c)(1)(ii)(B): The employer's Exposure Control Plan did not include the schedule and/or methods of implementation for 29 CFR 1910.1030(e), HIV and HBV Research Laboratories and Production Facilities:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 3 1 29 CFR 1910.1030(c)(1)(ii)(B): The employer's Exposure Control Plan did not include the schedule and/or method of implementation for 29 CFR 1910.1030(f), Hepatitis B Vaccination and Post-Exposure Evaluation and Follow-up:
OPTION 4 2 29 CFR 1910.1030(c)(1)(ii)(B): The employer's Exposure Control Plan did not include the schedule and/or method of implementation for 29 CFR 1910.1030(g), Communication of Hazards to Employees:
OPTION 5 3 29 CFR 1910.1030(c)(1)(ii)(B): The employer's Exposure Control Plan did not include the schedule and/or method of implementation for 29 CFR 1910.1030(h), Recordkeeping:
4 29 CFR 1910.1030(c)(1)(ii)(C): The employer's Exposure Control Plan did not include the procedure for the evaluation of circumstances surrounding exposure incidents, as required by 29 CFR 1910.1030(f)(3)(i):
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(c)(1)(iii): The employer did not ensure that a copy of the Exposure Control Plan was accessible to employees, in accordance with 29 CFR 1910.20(e):
OPTION 1 2 29 CFR 1910.1030(c)(1)(iv): The Exposure Control Plan was not reviewed and/or updated annually:
OPTION 2 3 29 CFR 1910.1030(c)(1)(iv): The Exposure Control Plan was not reviewed and/or updated when necessary to reflect new or modified tasks and procedures which affect occupational exposure and to reflect new or revised employee positions with occupational exposure:
4 29 CFR 1910.1030(c)(2)(i): The employer having employees with occupationally exposure did not prepare an exposure determination:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(c)(2)(i)(A): The exposure determination did not include a list of all job classifications in which all employees in those job classifications had occupational exposure:
2 29 CFR 1910.1030(c)(2)(i)(B): The exposure determination did not include a list of all job classifications in which some employees have occupational exposure:
3 29 CFR 1910.1030(c)(2)(i)(C): The exposure determination did not include a list of all tasks and procedures or groups of closely related tasks and procedures in which occupational exposure occurs and that are performed by employees in job classifications listed in 29 CFR 1910.1030(c)(2)(i)(B):
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(1): Universal precautions were not observed to prevent contact with blood or other potentially infectious materials:
OPTION 1 2 29 CFR 1910.1030(d)(2)(i): Engineering and/or work practice controls were not used to eliminate or minimize employees' occupational exposure:
OPTION 2 3 29 CFR 1910.1030(d)(2)(i): Personal protective equipment was not used where occupational exposure remained after the institution of engineering and/or work practice controls:
4 29 CFR 1910.1030(d)(2)(ii): Engineering controls were not examined or maintained, and replace on a regular schedule to ensure their effectiveness:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(2)(iii): The employer did not provide hand washing facilities readily accessible to employees occupational exposure:
2 29 CFR 1910.1030(d)(2)(iv): When provisions for hand washing facilities was not feasible, the employer did not provide either appropriate antiseptic hand cleanser in conjunction with clean cloth/paper towels or antiseptic towelettes to employees with occupational exposure:
3 29 CFR 1910.1030(d)(2)(v): The employer did not ensure that employees occupationally exposed to blood or other potentially infectious materials washed their hands immediately or as soon as feasible after removal of gloves or other personal protective equipment:
4 29 CFR 1910.1030(d)(2)(vi): The employer did not ensure that employees washed their hands or any other skin with soap and water, or flush mucous membranes with water immediately or as soon as feasible following contact of such body areas with blood or other potentially infectious materials:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(2)(vii): Contaminated needles were sheared or broken:
2 29 CFR 1910.1030(d)(2)(vii)(A): Contaminated needles or other sharps materials were bent, recapped, or removed:
3 29 CFR 1910.1030(d)(2)(vii)(B): Bending, recapping, or needle removal was not accomplished through the use of a mechanical device or a one-handed technique:
4 29 CFR 1910.1030(d)(2)(viii): Immediately or as soon as possible after use, contaminated sharps were not placed in appropriate containers until properly reprocessed:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(2)(viii)(A): Containers used to hold contaminated sharps were not puncture resistant:
2 29 CFR 1910.1030(d)(2)(viii)(B): Containers used to hold contaminated reusable sharps were not labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1):
3 29 CFR 1910.1030(d)(2)(viii)(C): Containers used to hold contaminated reusable sharps were not leakproof on the sides or bottom:
4 29 CFR 1910.1030(d)(2)(ix): Employee(s) ate, drank, smoked, applied cosmetics or lip balm, or handling contact lenses in work areas where there was a reasonable likelihood of occupational exposure:
5 29 CFR 1910.1030(d)(2)(x): Food or drink was kept in refrigerators, freezers, or cabinets or on countertops, shelves or benchtops where blood or other potentially infectious materials were present:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(2)(xi): Procedure(s) involving blood or other potentially infectious materials were not performed in such a manner as to minimize splashing, spraying, spattering, or generation of droplets of these substances:
2 29 CFR 1910.1030(d)(2)(xii): Employee(s) were engaged in the mouth pipetting/suctioning of blood or other potentially infectious materials:
3 29 CFR 1910.1030(d)(2)(xiii): Specimens of blood or other infectious materials were not placed in a container which prevented leakage during collection, handling, processing, storage, transport or shipping:
OPTION 1 4 29 CFR 1910.1030(d)(2)(xiii)(A): The container for storage, transport, or shipping of specimens of blood or other infectious materials was not labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1)(i):
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(d)(2)(xiii)(A): The container for storage, transport, or shipping of specimens of blood or other infectious materials was not closed prior to being stored, transported or shipped:
OPTION 1 2 29 CFR 1910.1030(d)(2)(xiii)(B): When outside contamination of the primary container for the storage, transport, or shipping of specimens of blood or other infectious materials occurred, the primary container was not placed within a second container which would prevented leakage during handling, processing, storage, transport, or shipping:
OPTION 2 3 29 CFR 1910.1030(d)(2)(xiii)(B): When outside contamination of the primary container for the storage, transport, or shipping of specimens of blood or other infectious materials occurred and the primary container was placed within a second container which was not labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1):
4 29 CFR 1910.1030(d)(2)(xiii)(C): When the specimen of blood or other infectious materials could puncture the primary container used for the storage, transport, or shipping of the specimen, and the primary container was not placed within a second container which was puncture-resistant:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 1 1 29 CFR 1910.1030(d)(2)(xiv): Equipment which became contaminated with blood or other potentially infectious materials was not examined prior to servicing or shipping and decontaminated as necessary:
2 29 CFR 1910.1030(d)(2)(xiv)(A): A readily observable label, as required by 29 CFR 1910.1030(g)(1)(i)(H), was not attached to the equipment stating which portions remain contaminated:
3 29 CFR 1910.1030(d)(2)(xiv)(B): The employer did not ensure that information was conveyed to all affected employees, the servicing representative, and/or the manufacturer, as appropriate, prior to handling, servicing or shipping of equipment that was contaminated with blood or other potentially infectious materials, so that appropriate precautions would be taken:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(3)(i): When there was occupational exposure, the employer did not provide, at no cost to the employee, appropriate personal protective equipment such as, but not limited to, gloves, gowns, laboratory coats, face shields, masks, eye protection, mouthpieces, resuscitation bags, pocket masks, or other ventilation devices:
2 29 CFR 1910.1030(d)(3)(ii): The employer did not ensure that the employee used appropriate personal protective equipment when there was occupational exposure:
OPTION 1 3 29 CFR 1910.1030(d)(3)(iii): The employer did not ensure that appropriate personal protective equipment in the appropriate sizes was readily accessible at the worksite or issued to employees when there was occupational exposure:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(d)(3)(iii): Hypoallergenic gloves, glove liners, powderless gloves, or other similar alternatives were not readily accessible to those employees who were allergic to the gloves normally provided:
2 29 CFR 1910.1030(d)(3)(iv): The employer did not clean, launder, or dispose of personal protective equipment required by 29 CFR 1910.1030(d) and (e), at no cost to the employee:
3 29 CFR 1910.1030(d)(3)(v): The employer did not repair or replace personal protective equipment as needed to maintain its effectiveness against exposure to blood or other potentially infectious materials, at no cost to the employee:
4 29 CFR 1910.1030(d)(3)(vi): Garments penetrated by blood or other potentially infectious materials were not removed immediately or as soon as feasible:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(3)(vii): Personal protective equipment was not removed prior to leaving the work area:
2 29 CFR 1910.1030(d)(3)(viii): When personal protective equipment was removed, it was not placed in an appropriately designated area or container for storage, washing, decontamination or disposal, after removal:
OPTION 1 3 29 CFR 1910.1030(d)(3)(ix): Gloves were not worn when it was reasonably anticipated that the employee might have had hand contact with blood or other potentially infectious materials, mucous membranes, or non-intact skin:
OPTION 2 4 29 CFR 1910.1030(d)(3)(ix): Gloves were not worn by employees when performing vascular access procedures:
OPTION 3 5 29 CFR 1910.1030(d)(3)(ix): Gloves were not worn when handling or touching contaminated items or surfaces:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(3)(ix)(A): Disposable (single use) gloves, such as surgical or examination gloves, were not replaced as soon as practical when contaminated or as soon as feasible when they were torn,or punctured, or when their ability to function as a barrier was compromised:
2 29 CFR 1910.1030(d)(3)(ix)(B): Disposable (single use) gloves were washed or decontaminated for re-use:
3 29 CFR 1910.1030(d)(3)(ix)(C): Utility gloves were not discarded when they were cracked, peeling, torn, or punctured, exhibited other signs of deterioration or when their ability to function as a barrier was compromised:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(3)(x): Masks in combination with eye protection devices, such as goggles or glasses with solid side shields, or chin-length face shields, were not worn whenever splashes, spray, spatter or droplets of blood or other potentially infectious materials could be generated and eye, nose, or mouth contamination could be reasonably anticipated:
2 29 CFR 1910.1030(d)(3)(xi): Appropriate protective clothing such as, but not limited to, gowns, aprons, lab coats, clinic jackets, or similar outer garments were not worn in occupational exposure situations:
3 29 CFR 1910.1030(d)(3)(xii): Surgical caps, hoods, shoe covers, or boots were not worn in instances when gross contamination from blood or other potentially infectious materials could have been reasonably anticipated:
OPTION 1 4 29 CFR 1910.1030(d)(4)(i): The employer did not ensure that the worksite was maintained in a clean or sanitary condition:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(d)(4)(i): The employer did not determine or implement an appropriate written schedule for cleaning or method of decontamination based upon the location within the facility, type of surface to be cleaned, type of soil present and tasks or procedures being performed in the area:
2 29 CFR 1910.1030(d)(4)(ii): Equipment, environmental surfaces, or working surfaces were not cleaned and decontaminated after contact with blood or other potentially infectious materials:
OPTION 1 3 29 CFR 1910.1030(d)(4)(ii)(A): Contaminated work surfaces were not decontaminated with an appropriate disinfectant after completion of procedures:
OPTION 2 4 29 CFR 1910.1030(d)(4)(ii)(A): Contaminated work surfaces were not decontaminated immediately or as soon as feasible when surfaces were overly contaminated or after any spill of blood or other potentially infectious materials:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 3 1 29 CFR 1910.1030(d)(4)(ii)(A): Contaminated work surfaces were not decontaminated at the end of the work shift when the surface might have become contaminated during the shift:
OPTION 1 2 29 CFR 1910.1030(d)(4)(ii)(B): Protective coverings, such as plastic wrap, aluminum foil, or imperviously-backed absorbent paper used to cover equipment and environmental surfaces, were not removed or replaced as soon as feasible when they became overly contaminated with blood or other potentially infectious materials:
OPTION 2 3 29 CFR 1910.1030(d)(4)(ii)(B): Protective coverings, such as plastic wrap, aluminum foil, or imperviously-backed absorbent paper used to cover equipment and environmental surfaces, were not removed or replaced at the end of the workshift when they might have become contaminated during the shift:
OPTION 1 4 29 CFR 1910.1030(d)(4)(ii)(C): Bins, pails, cans or similar receptacles intended for reuse which had a reasonable likelihood for becoming contaminated with blood or other potentially infectious materials were not inspected or decontaminated on a regularly scheduled basis:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(d)(4)(ii)(C): All bins, pails, cans and similar receptacles intended for reuse which had a reasonable likelihood for becoming contaminated with blood or other potentially infectious materials were not cleaned or decontaminated immediately or as soon as feasible after visible contamination:
OPTION 1 2 29 CFR 1910.1030(d)(4)(ii)(D): Broken glassware which could have been contaminated was picked up directly with the hands:
OPTION 2 3 29 CFR 1910.1030(d)(4)(ii)(D): Broken glassware which could been contaminated was not cleaned up using mechanical means, such as a brush and dust pan, tongs, or forceps:
4 29 CFR 1910.1030(d)(4)(ii)(E): Reusable sharps that were contaminated with blood or other potentially infectious material were not stored or processed in a manner that required employees to reach by hand into the containers where these sharps had been placed:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(4)(iii)(A)(1)(i): Contaminated sharps were not discarded immediately or as soon as feasible in containers that were closable:
2 29 CFR 1910.1030(d)(4)(iii)(A)(1)(ii): Contaminated sharps were not discarded immediately or as soon as feasible in containers that were puncture-resistant:
3 29 CFR 1910.1030(d)(4)(iii)(A)(1)(iii): Contaminated sharps were not discarded immediately or as soon as feasible in containers that were leakproof on sides and bottom:
4 29 CFR 1910.1030(d)(4)(iii)(A)(1)(iv): Contaminated sharps were not discarded immediately or as soon as feasible in containers that were labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1)(i):
5 29 CFR 1910.1030(d)(4)(iii)(A)(2)(i): During use, containers for contaminated sharps were not easily accessible to personnel or located as close as was feasible to the immediate area where sharps were used or could be reasonably anticipated to be found (e.g., laundries):
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(4)(iii)(A)(2)(ii): During use, containers for contaminated sharps were not maintained upright throughout use:
2 29 CFR 1910.1030(d)(4)(iii)(A)(2)(iii): During use, containers for contaminated sharps were not replaced routinely or were allowed to be overfilled:
3 29 CFR 1910.1030(d)(4)(iii)(A)(3)(i): Containers of contaminated sharps were moved from the area of use, and the containers were not closed immediately prior to removal or replacement to prevent spillage or protrusion of contents during handling, storage, transport, or shipping:
4 29 CFR 1910.1030(d)(4)(iii)(A)(3)(ii): Contaminated containers of sharps were moved from the area of use and were not placed in a secondary container when leakage from the primary container was possible:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(4)(iii)(A)(3)(ii)(A): Containers of contaminated sharps were moved from the area of use within a secondary container because leakage was possible and the second container was not closable:
2 29 CFR 1910.1030(d)(4)(iii)(A)(3)(ii)(B): Containers for contaminated sharps were moved from the area of use within a secondary container because leakage was possible and the second container was not constructed to contain all contents or prevent leakage during handling, storage, transport or shipping:
4 29 CFR 1910.1030(d)(4)(iii)(A)(4): Reusable containers for contaminated sharps were opened, emptied, or cleaned manually or in another manner which exposed employees to the risk of percutaneous injury:
5 29 CFR 1910.1030(d)(4)(iii)(B)(1)(i): Regulated waste (other than contaminated sharps) was placed in containers which were not closable:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(4)(iii)(B)(1)(ii): Regulated waste was placed in containers which were not constructed to contain all contents or prevent leakage of liquids during handling, storage, transport or shipping:
2 29 CFR 1910.1030(d)(4)(iii)(B)(1)(iii): Regulated waste was placed in containers which were not labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1)(i):
3 29 CFR 1910.1030(d)(4)(iii)(B)(1)(iv): Regulated waste was placed in containers which were not closed prior to removal to prevent spillage or protrusion of contents during handling, storage, transport or shipping:
4 29 CFR 1910.1030(d)(4)(iii)(B)(2): When outside contamination of the regulated waste container occurred, and it was not placed in a second container:
5 29 CFR 1910.1030(d)(4)(iii)(B)(2)(i): When outside contamination of the regulated waste container occurred, and it was placed in a second container which was not closable:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(4)(iii)(B)(2)(ii): When outside contamination of the regulated waste container occurred, and it was placed in a second container which was not constructed to contain all contents or prevent leakage of fluids during handling, storage, transport or shipping:
2 29 CFR 1910.1030(d)(4)(iii)(B)(2)(iii): When outside contamination of the regulated waste container occurred, and it was placed in a second container which was not labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1)(i):
3 29 CFR 1910.1030(d)(4)(iii)(B)(2)(iv): Outside contamination of the regulated waste container occurred, and it was placed in a second container which was not closed prior to removal to prevent spillage or protrusion of contents during handling, storage, transport or shipping:
4 29 CFR 1910.1030 (d)(4)(iii)(C): Disposal of all regulated waste was not in accordance with applicable regulations of the United States, a State, a Territory, or a political subdivision of a State or Territory:
5 29 CFR 1910.1030(d)(4)(iv)(A): Contaminated laundry was unnecessarily handled or was handled with excessive agitation:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 1 1 29 CFR 1910.1030 (d)(4)(iv)(A)(1): Contaminated laundry was not bagged or containerized at the location where it was used:
OPTION 2 2 29 CFR 1910.1030(d)(4)(iv)(A)(1): Contaminated laundry was sorted or rinsed in the location of use:
3 29 CFR 1910.1030 (d)(4)(iv)(A)(2): Contaminated laundry was not placed and/or transported in bags or containers which were labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1)(i):
4 29 CFR 1910.1030 (d)(4)(iv)(A)(3): Contaminated laundry was wet and presented a reasonable likelihood of soak-through of or leakage from the bag or container, the laundry was not placed or transported in bags or containers which prevented soak-through and/or leakage of fluids to the exterior:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(d)(4)(iv)(B): The employer did not ensure that employees who had contact with contaminated laundry wore protective gloves and other appropriate personal protective equipment:
2 29 CFR 1910.1030(d)(4)(iv)(C): Contaminated laundry was shipped off site to a second facility which did not utilize Universal Precautions in the handling of all laundry and the laundry was not placed in bags or containers which were labeled or color-coded in accordance with 29 CFR 1910.1030(g)(1)(i):
3 29 CFR 1910.1030(e)(2)(i): Regulated waste from a research laboratory or production facility was not either incinerated or decontaminated by a method such as autoclaving known to effectively destroy bloodborne pathogens:
4 29 CFR 1910.1030(e)(2)(ii)(A): Laboratory doors in a research laboratory or production facility were not kept closed when work involving HIV or HBV was in progress:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(e)(2)(ii)(B): Contaminated materials from a research laboratory or production facility that were to be decontaminated at a site away from the work area were not placed in a durable, leakproof, labeled or color-coded container that was closed before being removed from the work area:
OPTION 1 2 29 CFR 1910.1030(e)(2)(ii)(C): Access to the work area in a research laboratory or production facility was not limited to authorized persons:
OPTION 2 3 29 CFR 1910.1030(e)(2)(ii)(C): Written policies or procedures were not established in the research laboratory or production facility, whereby only persons who have been advised of the potential biohazard, who met any specific entry requirements, and who complied with all entry and exit procedures be allowed to enter the work areas and animal rooms:
4 29 CFR 1910.1030(e)(2)(ii)(D): A hazard warning sign incorporating the universal biohazard symbol complying with 29 CFR 1910.1030(g)(1)(ii) was not posted on all access doors where other potentially infectious materials or infected animals were present in the work area or containment module in the research laboratory or production facility:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(e)(2)(ii)(E): Activities involving other potentially infectious materials were conducted outside a biological safety cabinet or other physical-containment devices within the containment module in the research laboratory or production facility:
OPTION 1 2 29 CFR 1910.1030(e)(2)(ii)(F): Laboratory coats, gowns, smocks, uniforms or other appropriate protective clothing was not used in the work area or animal rooms in the research laboratory or production facility:
OPTION 2 3 29 CFR 1910.1030(e)(2)(ii)(F): Protective clothing used in the research laboratory or production facility was worn outside the work area:
OPTION 3 4 29 CFR 1910.1030(e)(2)(ii)(F): Protective clothing used in the research laboratory or production facility was not decontaminated before being laundered:
OPTION 1 5 29 CFR 1910.1030(e)(2)(ii)(G): Special care was not taken to avoid skin contact with other potentially infectious materials in the research laboratory or production facility:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(e)(2)(ii)(G): Gloves were not worn when handling infected animals or when making hand contact with potentially infectious materials in the research laboratory or production facility:
2 29 CFR 1910.1030(e)(2)(ii)(H): Before disposal waste from work areas and animal rooms of the research laboratory or production facility was not incinerated and decontaminated by a method such as autoclaving known to effectively destroy bloodborne pathogens:
OPTION 1 3 29 CFR 1910.1030(e)(2)(ii)(I): Vacuum lines in the research laboratory or production facility were not protected with liquid disinfectant traps or high-efficiency particulate air (HEPA) filters and filters of equivalent or superior efficiency:
OPTION 2 4 29 CFR 1910.1030(e)(2)(ii)(I): The liquid disinfectant traps or high efficiency particulate air (HEPA) filters or equivalent filters, that protected vacuum lines in the research laboratory or production facility, were not checked routinely or maintained or replaced as necessary:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 1 1 29 CFR 1910.1030(e)(2)(ii)(J): Hypodermic needles and syringes were used for a purpose other than parenteral injection and aspiration of fluids from laboratory animals or diaphragm bottles in the research laboratory or production facility:
OPTION 2 2 29 CFR 1910.1030(e)(2)(ii)(J): Devices other than needle-locking syringes and disposable syringe-needle units (i.e., the needle is integral to the syringe) were used for the injection or aspiration of other potentially infectious materials in the research laboratory or production facility:
OPTION 3 3 29 CFR 1910.1030(e)(2)(ii)(J): Extreme caution was not used when needles or syringe were handled in the research laboratory or production facility:
OPTION 4 4 29 CFR 1910.1030(e)(2)(ii)(J): A needle used in the research laboratory or production facility was bent, sheared, replaced in a sheath or guard, or removed from the syringe following use:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 5 1 29 CFR 1910.1030(e)(2)(ii)(J): Before reuse or disposal in the research laboratory or production facility, needles or syringes were not promptly placed in a puncture resistant container:
OPTION 6 2 29 CFR 1910.1030(e)(2)(ii)(J): Before reuse or disposal in the research laboratory or production facility, needles or syringes were not autoclaved and decontaminated:
3 29 CFR 1910.1030(e)(2)(ii)(K): Spills in the research laboratory or production facility were not immediately contained or cleaned up by appropriate professional staff or others properly trained or equipped to work with potentially concentrated infectious materials:
4 29 CFR 1910.1030(e)(2)(ii)(L): A spill or accident that resulted in an exposure incident in the research laboratory or production facility was not immediately reported to the laboratory director or other responsible person:
OPTION 1 5 29 CFR 1910.1030(e)(2)(ii)(M): A biosafety manual was not prepared and adopted or periodically reviewed or updated at least annually in the research laboratory or production facility:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(e)(2)(ii)(M): Personnel in the research laboratory or production facility were not advised of potential hazards and were not required to read and follow instructions on practices or procedures listed in the biosafety manual:
2 29 CFR 1910.1030(e)(2)(iii)(A): Certified biological safety cabinets (Class I, II, or III) and other appropriate combinations of personal protection equipment or physical containment devices, such as special protective clothing, respirators, centrifuge safety cups, sealed centrifuge rotors, or containment caging for animals, were not used for all activities with other potentially infectious materials that pose a threat of exposure to droplets, splashes, spills or aerosols in the research laboratory or production facility:
3 29 CFR 1910.1030(e)(2)(iii)(B): Biological safety cabinets were not certified when they were installed, when they were moved, or at least annually:
4 29 CFR 1910.1030(e)(3)(i): Each research laboratory did not contain a facility for hand washing or an eye wash facility which was readily available within the work area:
5 29 CFR 1910.1030(e)(3)(ii): An autoclave for decontamination of regulated waste was not available in a research laboratory:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 1 1 29 CFR 1910.1030(e)(4)(i): Work areas in the production facility were not separated from areas that were open to unrestricted traffic flow within the building:
OPTION 2 2 29 CFR 1910.1030(e)(4)(i): Passage into work areas from access corridors or other contiguous areas in the production facility was not through two sets of doors:
OPTION 1 3 29 CFR 1910.1030(e)(4)(ii): The surfaces of doors, walls, floors or ceilings in the work areas of the HIV and HBV production facility, were not water resistant so they could be easily cleaned:
OPTION 2 4 29 CFR 1910.1030(e)(4)(ii): Penetrations in the surfaces of doors, walls, floors, or ceilings were not sealed and/or capable of being sealed to facilitate decontamination:
OPTION 1 5 29 CFR 1910.1030(e)(4)(iii): A work area in the production facility did not contain a sink for washing hands or a readily available eye wash facility:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(e)(4)(iii): The sink in the work area in the production facility was not foot-operated, elbow-operated or automatically operated:
OPTION 3 2 29 CFR 1910.1030(e)(4)(iii): The sink in a work area in the production facility was not located near the exit door of the work area:
3 29 CFR 1910.1030(e)(4)(iv): Access doors to the work area or containment module in the production facility were not self-closing:
4 29 CFR 1910.1030(e)(4)(v): An autoclave for decontamination of regulated waste was not available within and/or as near as possible to the work area in the production facility:
OPTION 1 5 29 CFR 1910.1030(e)(4)(vi): A ducted exhaust-air ventilation system in the production facility was not provided:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(e)(4)(vi): The ducted exhaust-air ventilation system in the production facility did not create directional airflow that drew air into the work area through the entry area:
OPTION 3 2 29 CFR 1910.1030(e)(4)(vi): The exhaust air of the ventilation system in the production facility was recirculated to other areas of the building:
OPTION 4 3 29 CFR 1910.1030(e)(4)(vi): The exhaust air of the ventilation system in the production facility was not discharged to the outside:
OPTION 5 4 29 CFR 1910.1030(e)(4)(vi): The exhaust air of the ventilation system in the production facility was not dispersed away from occupied areas or air intakes:
OPTION 6 5 29 CFR 1910.1030(e)(4)(vi): The proper direction of the airflow (i.e., into the work area) in the production facility was not verified:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(f)(1)(ii)(A): The employer did not ensure that medical evaluations and procedures including the hepatitis B vaccine and vaccination series, post-exposure evaluation, or follow-up, including prophylaxis, were made available at no cost to the employee:
2 29 CFR 1910.1030(f)(1)(ii)(B): The employer did not ensure that all medical evaluations and procedures including the hepatitis B vaccine and vaccination series, post-exposure evaluation, or follow-up, including prophylaxis, were made available to the employee at a reasonable time or place:
3 29 CFR 1910.1030(f)(1)(ii)(C): The employer did not ensure that all medical evaluations or procedures including the hepatitis B vaccine, vaccination series, post-exposure evaluation, or follow-up, including prophylaxis, were performed by or under the supervision of a licensed physician or by or under the supervision of another licensed health care professional:
4 29 CFR 1910.1030(f)(1)(ii)(D): The employer did not ensure that all medical evaluations or procedures including the hepatitis B vaccine, vaccination series, post-exposure evaluation, or follow-up, including prophylaxis, were provided according to recommendations of the U.S.Public Health Service current at the time the evaluations or procedures took place:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(f)(1)(iii): The employer did not ensure that laboratory tests were conducted by an accredited laboratory at no cost to the employee:
2 29 CFR 1910.1030(f)(2)(i): Hepatitis B vaccination was not made available after the employee had received the training required in 29 CFR 1910.1030(g)(2)(vii)(I) or within 10 working days of initial assignment to employees who had occupational exposure to blood or other potentially infectious materials:
3 29 CFR 1910.1030(f)(2)(ii): The employer made participation in a prescreening program a prerequisite for receiving hepatitis B vaccination:
4 29 CFR 1910.1030(f)(2)(iii): Hepatitis B vaccination was not made available to employees who initially declined the hepatitis B vaccination but at a later date, while still covered under this standard, decided to accept the vaccination:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(f)(2)(iv): The employer did not ensure that employees who declined to accept the hepatitis B vaccination offered by the employer signed the statement in appendix A:
2 29 CFR 1910.1030(f)(2)(v): Booster dose(s) of hepatitis B vaccine were recommended by the U.S. Public Health Service and the employer did not make the dose(s) available to the employees in accordance with 29 CFR 1910.1030(f)(1)(ii):
3 29 CFR 1910.1030(f)(3): Following a report of an exposure incident the employer did not make immediately available to the exposed employee a confidential medical evaluation or follow-up:
4 29 CFR 1910.1030(f)(3)(i): The post-exposure evaluation and follow-up of an exposure incident did not include documentation of the route(s) of exposure or the circumstances under which the exposure incident occurred:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(f)(3)(ii): The post-exposure evaluation and follow-up of an exposure incident did not include the identification or documentation of the source individual:
2 29 CFR 1910.1030(f)(3)(ii)(A): The post-exposure evaluation and follow-up of an exposure incident did not include testing the source individual's blood as soon as feasible and after consent was obtained in order to determine HBV and HIV infectivity:
3 29 CFR 1910.1030(f)(3)(ii)(C): Results of the source individual's testing as a result of a post-exposure evaluation and follow-up of an exposure incident were not made available to the exposed employee, or the employee was not informed of applicable laws or regulations concerning disclosure of the identity or infectious status of the source individual:
4 29 CFR 1910.1030(f)(3)(iii)(A): The post-exposure evaluation and follow-up of an exposure incident did not include the collection of the exposed employee's blood as soon as feasible or test for HBV and HIV serological status after consent was obtained:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(f)(3)(iii)(B): After an exposure incident, blood samples were not preserved for 90 days when an employee consented to baseline blood collection but did not consent to HIV serological testing:
2 29 CFR 1910.1030(f)(3)(iv): The post-exposure evaluation and follow-up of an exposure incident did not include post-exposure prophylaxis, when medically indicated, as recommended by the U.S. Public Health Service:
3 29 CFR 1910.1030(f)(3)(v): The post-exposure evaluation and follow-up of an exposure incident did not include counseling:
4 29 CFR 1910.1030(f)(3)(vi): The post-exposure evaluation and follow-up of an exposure incident did not include evaluation of reported illnesses:
5 29 CFR 1910.1030(f)(4)(i): The employer did not ensure that the health care professional responsible for the employee's Hepatitis B vaccination was provided a copy of this regulation:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(f)(4)(ii)(A): The employer did not ensure that the health care professional evaluating an employee after an exposure incident was provided with a copy of this regulation:
2 29 CFR 1910.1030(f)(4)(ii)(B): The employer did not ensure that the health care professional evaluating an employee after an exposure incident was provided with a description of the exposed employee's duties as they related to the exposure incident:
3 29 CFR 1910.1030(f)(4)(ii)(C): The employer did not ensure that the health care professional evaluating an employee after an exposure incident was provided with documentation of the route(s) of exposure or circumstances under which exposure occurred:
4 29 CFR 1910.1030(f)(4)(ii)(D): The employer did not ensure that the health care professional evaluating an employee after an exposure incident was provided with results of the source individual's blood testing, when it was available:
5 29 CFR 1910.1030(f)(4)(ii)(E): The employer did not ensure that the health care professional evaluating an employee after an exposure incident was provided with all medical records relevant to the appropriate treatment of the employee, including vaccination status, which were the employer's responsibility to maintain:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(f)(5): The employer did not obtain or provide the employee with a copy of the evaluating health care professional's written opinion within 15 days of the completion of the evaluation:
2 29 CFR 1910.1030(f)(5)(i): The health care professional's written opinion for Hepatitis B vaccination did not state whether Hepatitis B vaccination was indicated for an employee, or if the employee had received such vaccination:
3 29 CFR 1910.1030(f)(5)(ii)(A): The health care professional's written opinion for post-exposure evaluation and follow-up did not state that the employee had been informed of just the evaluation results:
4 29 CFR 1910.1030(f)(5)(ii)(B): The health care professional's written opinion for post-exposure evaluation and follow-up did not state that the employee had been told about any medical conditions resulting from exposure to blood or other potentially infectious materials which required further evaluation or treatment:
5 29 CFR 1910.1030(f)(5)(iii): Findings or diagnoses other than those required by 29 CFR 1910.1030(f)(5) were not confidential or were included in the report:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 1 1 29 CFR 1910.1030(g)(1)(i)(A): Warning labels were not affixed to containers of regulated waste, refrigerators, or freezers containing blood or other potentially infectious material:
OPTION 2 2 29 CFR 1910.1030(g)(1)(i)(A): Warning labels were not affixed to containers used to store, transport or ship blood or other potentially infectious materials:
3 29 CFR 1910.1030(g)(1)(i)(B): Labels required by this standard did not include the biohazard symbol and the word "Biohazard" as defined in this standard:
4 29 CFR 1910.1030(g)(1)(i)(C): Labels required by this section were not fluorescent orange or orange-red, or predominantly so, or with lettering or symbols in a contrasting color:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(g)(1)(i)(D): Labels were not affixed as close as feasible to the container by string, wire, adhesive, or other method that prevents their loss or unintentional removal:
2 29 CFR 1910.1030(g)(1)(i)(H): Labels required for contaminated equipment were not in accordance with this paragraph or did not also state which portions of the equipment remained contaminated:
3 29 CFR 1910.1030(g)(1)(ii)(A): The employer did not post at the entrance to work areas specified in 29 CFR 1910.1030(e), HIV and HBV Research Laboratory and Production Facilities; signs bearing the legend depicted and the word "Biohazard":
4 29 CFR 1910.1030(g)(1)(ii)(B): Signs posted at the entrance to work areas specified in 29 CFR 1910.1030(e), HIV and HBV Research Laboratory and Production Facilities, were not fluorescent orange-red or predominantly so, or with lettering and symbols in a contrasting color:
OPTION 1 5 29 CFR 1910.1030(g)(2)(i): The employer did not ensure that employees with occupational exposure participated in a training program:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance OPTION 2 1 29 CFR 1910.1030(g)(2)(i): The training program provided by the employer for employees with occupational exposure was not provided at no cost or was provided during working hours:
2 29 CFR 1910.1030(g)(2)(ii)(A): The employer did not ensure that training provided to employees with occupational exposure at the time of initial assignment to tasks where occupational exposure might take place:
3 29 CFR 1910.1030)g)(2)(ii)(B): The employer did not ensure that the training was provided to employees with occupational exposure within 90 days after the effective date of the standard (June 4, 1992):
4 29 CFR 1910.1030(g)(2)(ii)(C): The employer did not ensure that training provided to employees with occupational exposure was conducted at least annually:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(g)(2)(iv): Annual training for employees with occupational exposure was not provided within one year of their previous training:
2 29 CFR 1910.1030(g)(2)(v): Employees were not provided additional training when changes such as modification of tasks or procedures or institution of new tasks or procedures affected the employee's occupational exposure:
3 29 CFR 1910.1030(g)(2)(vi): Material appropriate in content or vocabulary to educational level, literacy, or language of employees was not used in the bloodborne pathogen training program:
4 29 CFR 1910.1030(g)(2)(vii)(A): The bloodborne pathogens training program did not contain an accessible copy of the regulatory text of this standard and an explanation of its contents:
5 29 CFR 1910.1030(g)(2)(vii)(B): The bloodborne pathogens training program did not contain a general explanation of the epidemiology or symptoms of bloodborne diseases:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(g)(2)(vii)(C): The bloodborne pathogens training program did not contain an explanation of the modes of transmission of bloodborne pathogens:
2 29 CFR 1910.1030(g)(2)(vii)(D): The bloodborne pathogens training program did not contain an explanation of the employer's exposure control plan or the means by which the employee could obtain a copy of the written plan:
3 29 CFR 1910.1030(g)(2)(vii)(E): The bloodborne pathogens training program did not contain an explanation of the appropriate methods for recognizing tasks or other activities that might involve exposure to blood or other potentially infectious materials:
4 29 CFR 1910.1030(g)(2)(vii)(F): The bloodborne pathogens training program did not contain an explanation of the use or limitations of methods that would prevent or reduce exposure including appropriate engineering controls, work practices or personal protective equipment:
5 29 CFR 1910.1030(g)(2)(vii)(G): The bloodborne pathogens training program did not contain information on the types, proper use, location, removal, handling, decontamination, or disposal of personal protective equipment:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(g)(2)(vii)(H): The bloodborne pathogens training program did not contain an explanation of the basis for selection of personal protective equipment:
2 29 CFR 1910.1030(g)(2)(vii)(I): The bloodborne pathogens training program did not contain information on the hepatitis B vaccine, including information on its efficacy, safety, method of administration, the benefits of being vaccinated, or the fact that the vaccine and vaccination would be offered free of charge:
3 29 CFR 1910.1030(g)(2)(vii)(J): The bloodborne pathogens training program did not contain information on the appropriate actions to take or persons to contact in an emergency involving blood or other potentially infectious materials:
4 29 CFR 1910.1030(g)(2)(vii)(K): The bloodborne pathogens training program did not contain an explanation of the procedure to follow if an exposure incident occurred, including the method of reporting the incident or the medical follow-up that would be made available:
5 29 CFR 1910.1030(g)(2)(vii)(L): The bloodborne pathogens training program did not contain information on the post-exposure evaluation or follow-up that the employer was required to provide for the employee following an exposure incident:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(g)(2)(vii)(M): The bloodborne pathogens training program did not contain an explanation of the signs, labels, or color coding required by 29 CFR 1910.1030 (g)(1):
2 29 CFR 1910.1030(g)(2)(vii)(N): The bloodborne pathogens training program did not contain an opportunity for interactive questions or answers with the person conducting the training session:
3 29 CFR 1910.1030(g)(2)(viii): The person conducting the bloodborne pathogen training was not knowledgeable in the subject matter covered by the elements contained in the training program as it related to the workplace that the training would addressed:
4 29 CFR 1910.1030(g)(2)(ix)(A): The employer did not ensure that employees in the HIV or HBV research laboratory or production facility demonstrated proficiency in standard microbiological practices or techniques or in the practices or operations specific to the facility before being allowed to work with HIV or HBV:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(g)(2)(ix)(B): The employer did not ensure that employees in a research laboratory or production facility, had prior experience in the handling of human pathogens or tissue cultures before working with HIV or HBV:
OPTION 1 2 29 CFR 1910.1030(g)(2)(ix)(C): The employer did not ensure that employees had prior experience in the handling of human pathogens or tissue cultures before working with HIV or HBV in a research laboratory or production facility:
OPTION 2 3 29 CFR 1910.1030(g)(2)(ix)(C): In a research laboratory or production facility initial work activities included the handling of infectious agents:
OPTION 3 4 29 CFR 1910.1030(g)(2)(ix)(C): In a research laboratory or production facility a progression of work activities was not assigned as techniques were learned or proficiencies were developed:
OPTION 4 5 29 CFR 1910.1030(g)(2)(ix)(C): In a research laboratory or production facility the employer did not assure that employees participated in work activities involving infectious agents only after proficiency had been demonstrated
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(h)(1)(i): The employer did not establish records or in accordance with 29 CFR 1910.20, or maintain an accurate medical record for each employee with occupational exposure:
2 29 CFR 1910.1030(h)(1)(ii)(A): The medical record for an employee with occupational exposure did not include the name or social security number of the employee:
3 29 CFR 1910.1030(h)(1)(ii)(B): The medical record for an employee with occupational exposure did not include a copy of the employee's hepatitis B vaccination status, including the dates of all the hepatitis B vaccinations or any medical records relative to the employee's ability to receive vaccination as required by 29 CFR 1910.1030(f)(2):
4 29 CFR 1910.1030(h)(1)(ii)(C): The medical record for an employee with occupational exposure did not include a copy of results of examinations, medical testing, or follow-up procedures as required by 29 CFR 1910.1030(f)(3):
5 29 CFR 1910.1030(h)(1)(ii)(D): The medical record for an employee with occupational exposure did not include the employer's copy of the health care professional's written opinion as required by 29 CFR 1910.1030(f)(5):
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(h)(1)(ii)(E): The medical record for an employee with occupational exposure did not include a copy of the information provided to the healthcare professional as required by 29 CFR 1910.1030(f)(4)(ii)(B), (C), and (D):
2 29 CFR 1910.1030(h)(1)(iii)(A): The employer did not ensure that employee medical records required by 29 CFR 1910.1030 (h)(1) were kept confidential:
3 29 CFR 1910.1030(h)(1)(iii)(B): The employer did not ensure that employee medical records required by 29 CFR 1910.1030 (h)(1) were not disclosed or reported without the employee's expressed written consent to any person within or outside the workplace:
4 29 CFR 1910.1030(h)(1)(iv): The employer did not maintain employee medical records required by 29 CFR 1910.1030(h) for at least the duration of employment plus 30 years in accordance with 29 CFR 1910.20:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(h)(2)(i)(A): Employee training records for bloodborne pathogens did not include the dates of the training sessions:
2 29 CFR 1910.1030(h)(2)(i)(B): Employee training records for bloodborne pathogens did not include the contents or a summary of the training sessions:
3 29 CFR 1910.1030(h)(2)(i)(C): Employee training records for bloodborne pathogens did not include the names or qualifications of persons conducting the training:
4 29 CFR 1910.1030(h)(2)(i)(D): Employee training records for bloodborne pathogens did not include the names or job titles of all persons attending the training sessions:
5 29 CFR 1910.1030(h)(2)(ii): Employee training records for bloodborne pathogens were not maintained for 3 years from the date on which the training occurred:
OSHA Instruction CPL 2.35 CH-20 August 31, 1992 Office of General Industry Compliance Assistance 1 29 CFR 1910.1030(h)(3)(ii): Employee training records required by this paragraph were not provided upon request for examination or copying by the employee(s) or to employee representative in accordance with 29 CFR 1910.20:
2 29 CFR 1910.1030(h)(3)(iii): Employee medical records required by this paragraph were not provided upon request for examination or copying to the subject employee or to anyone having written consent of the subject employee in accordance with 29 CFR 1910.20:
3 29 CFR 1910.1030(h)(4)(i): The employer did not comply with the requirements involving transfer of records set forth in 29 CFR 1910.20(h):
4 29 CFR 1910.1030(h)(4)(ii): When employer is ceasing to do business and there is no successor employer to receive and retain the records for the prescribed period, the employer did not notify the Director of the National Institute of Occupational Safety and Health at least three months prior to their disposal or transmit them to the Director, when required by the Director to do so, within that three month period:
|
![]() |
![]() |
www.osha.gov | www.dol.gov |
Contact Us | Freedom of Information Act | Customer Survey Privacy and Security Statement | Disclaimers |
||
Occupational Safety & Health Administration 200 Constitution Avenue, NW Washington, DC 20210 |